Verender Badial - May 18, 2023 Form 4 Insider Report for Zura Bio Ltd (ZURA)

Role
Chief Financial Officer
Signature
/s/ Verender S. Badial
Stock symbol
ZURA
Transactions as of
May 18, 2023
Transactions value $
$0
Form type
4
Date filed
5/22/2023, 09:15 PM
Previous filing
Jul 14, 2021
Next filing
Jun 21, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ZURA Employee Share Option (Right to Buy) Award $0 +575K $0.00 575K May 18, 2023 Class A Ordinary Shares 575K $0.01 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Employee Share Option is a nil cost option granted under the Issuer's 2023 Equity Incentive Plan and the applicable UK Subplan.
F2 25% of the option shall become exercisable on May 18, 2024 and a further 2.083% of it shall become exercisable at the end of each month thereafter.